In dementia care relying only on randomized controlled trials can leave out a large amount of strong research that reflects ...

An HHS spokesperson said Dr. Jay Bhattacharya had concerns about the paper’s methodology. Some current or former CDC ...

Exon-skipping therapies for Duchenne muscular dystrophy, a class of drugs that triggered fierce regulatory debate when they ...

Abstract: In this article, we revisit a communication control co-design problem for a class of two-player stochas tic differential games on an infinite horizon. Each ‘player’ represents two active ...

Abstract: Safety and data efficiency are important concerns in data-driven control, especially for nonlinear systems with unknown dynamics and subject to disturbances. In this work, we consider a ...

Methods: A 12-week, parallel, single-blind randomized controlled trial was conducted with 123 participants (62/123, 50%, female; mean age 58.25 years, SD 9.46 years) recently diagnosed with T2D.

The impact of intensive blood pressure (BP) control on cognitive function in East Asian populations remains uncertain. We aimed to assess the effect of a lower systolic BP target on global cognitive ...

Average current-mode control, as shown in Figure 1, is common in continuous-conduction-mode (CCM) power factor correction (PFC). It has two loops: a voltage loop that works as an outer loop and a ...

This 40sqm cabin, known as The Pod, is designed as a complete living system. Every function — sleeping, cooking, working — is integrated with precision. Instead of space, the design prioritizes ...

First, it was Liquid Glass. Then it was the icons. And then it was the icons again (though it’s a different set of icons). Now, there’s something else about macOS Tahoe’s redesign that annoys the heck ...

A new study in the American Journal of Preventive Medicine reports findings from a randomized controlled trial—the gold standard study design in health research—showing that promoting drinking water ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...